Dr. Joel Bozue Named USAMRIID Civilian of the Quarter
Dr. Joel Bozue was named Civilian of the Quarter (Q3) at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Md. Bozue, a principal investigator in the Institute's Bacteriology Division, served as the U.S. Chairman of the Medical Biological Defense Working Group...
USAMRIID Focuses on Genome Sequencing to Detect Variants
The U.S. Army Medical Research Institute of Infectious Diseases's Center for Genome Sciences played a key role in support during the COVID-19 pandemic.
U.S. Army medical team helps Smithsonian National Zoo to protect endangered Red Pandas
A U.S. Army medical team contributed to an investigation into the cause of death of a Red Panda at the Smithsonian’s National Zoo and Conservation Biology Institute (NZCBI).
Researchers Detect Monkeypox Virus in Testes of Nonhuman Primate Survivors
For the first time, scientists have detected monkeypox virus in the testes of macaques during the acute phase of infection, according to research published online Oct. 17, 2022 in the journal Nature Microbiology.
To provide leading edge medical capabilities to deter and defend against current and emerging biological threat agents.
— Vision —
To advance medical biological defense to protect our military and the nation.
Since 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research. While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.
This Web site provides an introduction to the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and contains official information.
It is intended for interested members of the public, news media and Army Medical Department beneficiaries.
Please address questions and concerns about this website to the USAMRIID Webmaster via email.